ROIV
Roivant Sciences Ltd. · Healthcare
Director Keith S Manchester sold $32.7M of Roivant Sciences Ltd.
Sold$32,658,518
$26.64Price
1,225,784Shares
−7%Stake
What ROIV did after the filing
- The stock from Tue, Feb 17 open, $26.34
- +5.2%
- S&P 500, same days
- −4.4%
Measured over 30 trading days, to the Mar 31 close.
Traded Wed, Feb 11. Filed Fri, Feb 13, 4:02 PM ET, after the close. Returns use the Feb 17 open and the Mar 31 close. Not investment advice.